GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nippon Shinyaku Co Ltd (OTCPK:NPPNY) » Definitions » Days Sales Outstanding

Nippon Shinyaku Co (Nippon Shinyaku Co) Days Sales Outstanding : 109.93 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Nippon Shinyaku Co Days Sales Outstanding?

Nippon Shinyaku Co's average Accounts Receivable for the three months ended in Dec. 2023 was $330 Mil. Nippon Shinyaku Co's Revenue for the three months ended in Dec. 2023 was $274 Mil. Hence, Nippon Shinyaku Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 109.93.

The historical rank and industry rank for Nippon Shinyaku Co's Days Sales Outstanding or its related term are showing as below:

NPPNY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 110.68   Med: 136.47   Max: 163.15
Current: 118.34

During the past 13 years, Nippon Shinyaku Co's highest Days Sales Outstanding was 163.15. The lowest was 110.68. And the median was 136.47.

NPPNY's Days Sales Outstanding is ranked worse than
81.82% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 71.68 vs NPPNY: 118.34

Nippon Shinyaku Co's Days Sales Outstanding declined from Dec. 2022 (110.13) to Dec. 2023 (109.93).


Nippon Shinyaku Co Days Sales Outstanding Historical Data

The historical data trend for Nippon Shinyaku Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nippon Shinyaku Co Days Sales Outstanding Chart

Nippon Shinyaku Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 139.17 135.44 123.73 115.53 118.17

Nippon Shinyaku Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 110.13 127.61 114.65 121.38 109.93

Competitive Comparison of Nippon Shinyaku Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Shinyaku Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nippon Shinyaku Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nippon Shinyaku Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Nippon Shinyaku Co's Days Sales Outstanding falls into.



Nippon Shinyaku Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Nippon Shinyaku Co's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

Days Sales Outstanding (A: Mar. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count ) / Revenue (A: Mar. 2023 )*Days in Period
=( (364.133 + 334.315) / 2 ) / 1078.635*365
=349.224 / 1078.635*365
=118.17

Nippon Shinyaku Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (329.568 + 329.952) / 2 ) / 273.737*365 / 4
=329.76 / 273.737*365 / 4
=109.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nippon Shinyaku Co  (OTCPK:NPPNY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Nippon Shinyaku Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Nippon Shinyaku Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Nippon Shinyaku Co (Nippon Shinyaku Co) Business Description

Traded in Other Exchanges
Address
14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto, JPN, 601-8550
Nippon Shinyaku Co Ltd is a specialty and generic drug manufacturing company. Nippon's research and development activities include a focus on pharmaceuticals, nutraceuticals, safety and pharmacokinetics of drug seeds, genomic drug discovery, and nucleic acid drugs. The company also develops health food ingredients, preservatives, protein preparations, and spices. Nippon considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Nippon Shinyaku Co (Nippon Shinyaku Co) Headlines

No Headlines